Discussion about this post

User's avatar
Saurin Pandya's avatar

Re FCP monitoring: (1) Would giving collection kits to patients and have those mailed to labs not work? Seems cost and insurance coverage would be the key issues. (2) there are good nanosensors for biologic molecules currently in both universities and in startups. If FCP is durable at room temperature, maybe we could develop a "sensing" molecule that attaches with high specificity to FCP. This approach would take time to develop and test, but unit costs would be neglibly small, and time-to-result would be comparable to other @home strip tests like COVID, urine, pregnancy etc.

Expand full comment

No posts